The potential management of resistant infections with non-antibiotics.

The antimicrobial activity of synthetic, non-chemotherapeutic compounds, such as the phenothiazine, methylene blue, has been known since the time of Ehrlich (1854-1915). In this context the term 'non-antibiotics' is taken to include a variety of compounds which are employed in the management of pathological conditions of a non-infectious aetiology, but which modify cell permeability and have been shown to exhibit broad-spectrum antimicrobial activity. The antimicrobial properties of compounds such as phenothiazines, as well as those of other neurotropic compounds, have only been investigated sporadically, and their application to management of microbial infections has not been evaluated. A review of the literature, coupled with a number of more recent investigations, suggests that some of these and other membrane-active compounds enhance the activity of conventional antibiotics, eliminate natural resistance to specific antibiotics (reversal of resistance) and exhibit strong activity against multi-drug resistant forms of Mycobacterium tuberculosis. Thus non-antibiotics may have a significant role in the management of certain bacterial infections.

[1]  P. Ehrlich.  Ueber die Methylenblaureaction der lebenden Nervensubstanz , 1886 .

[2]  M. G. Sevag.  PREVENTION OF THE EMERGENCE OF ANTIBIOTIC-RESISTANT STRAINS OF BACTERIA BY ATABRINE. , 1964, Archives of biochemistry and biophysics.

[3]  H. Neu,et al.  Effect of N-acetylcysteine on antibiotic activity and bacterial growth in vitro , 1977, Journal of clinical microbiology.

[4]  H. Rosenkranz,et al.  Antimicrobial activity of local anesthetics: lidocaine and procaine. , 1970, The Journal of infectious diseases.

[5]  L. Amaral,et al.  Inhibition of the respiration of multi-drug resistant clinical isolates of Mycobacterium tuberculosis by thioridazine: potential use for initial therapy of freshly diagnosed tuberculosis. , 1996, The Journal of antimicrobial chemotherapy.

[6]  S. Niyogi,et al.  Antibacterial property of methyl-DOPA & development of antibiotic cross-resistances in m-DOPA mutants. , 1986, The Indian journal of medical research.

[7]  S. Levy,et al.  Active efflux mechanisms for antimicrobial resistance , 1992, Antimicrobial Agents and Chemotherapy.

[8]  J. Kristiansen,et al.  Membrane stabilizers inhibit potassium efflux from Staphylococcus aureus strain No. U2275. , 1982, Biochimica et biophysica acta.

[9]  A. J. Crowle,et al.  Chlorpromazine: a drug potentially useful for treating mycobacterial infections. , 1992, Chemotherapy.

[10]  P. Mårdh,et al.  Antibacterial activities of non-antibiotic drugs. , 1993, The Journal of antimicrobial chemotherapy.

[11]  Kristiansen Je.  The antimicrobial activity of non-antibiotics. Report from a congress on the antimicrobial effect of drugs other than antibiotics on bacteria, viruses, protozoa, and other organisms. , 1992 .

[12]  D. Nicolau,et al.  Influence of aspirin on development and treatment of experimental Staphylococcus aureus endocarditis , 1995, Antimicrobial agents and chemotherapy.

[13]  P. Cole,et al.  N-acetylcysteine potentiates the anti-pseudomonas activity of carbenicillin in vitro. , 1981, The Journal of infection.

[14]  P. Domenico,et al.  Reduction of capsular polysaccharide production in Klebsiella pneumoniae by sodium salicylate , 1989, Infection and immunity.

[15]  J. Kristiansen,et al.  Effect of selected neuroleptic agents and stereo-isomeric analogues on virus and eukaryotic cells. , 1991, Pharmacology & toxicology.

[16]  L. Amaral,et al.  Effects of chlorpromazine on the cell envelope proteins of Escherichia coli , 1991, Antimicrobial Agents and Chemotherapy.

[17]  F. Goldstein,et al.  Synergistic activity of trimethoprim-sulfamethoxazole on gram-negative bacilli: observations in vitro and in vivo. , 1973, The Journal of infectious diseases.

[18]  H. Neu.  Antimicrobial Chemotherapy, 1934–1994 , 1994 .

[19]  P. Ehrlich,et al.  Über die Wirkung des Methylenblau bei Malaria , 1960 .

[20]  J. Williams,et al.  Selective toxicity and concordant pharmacodynamics of antibiotics and other drugs , 1995 .

[21]  F. Forrest,et al.  Clinical, biochemical and post mortem studies on a patient treated with chlorpromazine. , 1963, Agressologie: revue internationale de physio-biologie et de pharmacologie appliquees aux effets de l'agression.

[22]  L. Amaral,et al.  Synergic effect of chlorpromazine on the activity of some antibiotics. , 1992, The Journal of antimicrobial chemotherapy.

[23]  M. Jacobs,et al.  In vitro activity of amiloride combined with tobramycin against Pseudomonas isolates from patients with cystic fibrosis , 1988, Antimicrobial Agents and Chemotherapy.

[24]  U. Schwarz,et al.  Penicillin-binding site on the Escherichia coli cell envelope , 1986, Journal of bacteriology.

[25]  S. Bradley,et al.  Retardation of the Emergence of Isoniazid-Resistant Mycobacteria by Phenothiazines and Quinacrine , 1969, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.